← SynDRA
SRA-737
SynDRA canonical compound SYN0039311 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CHEK1 |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CHEK1 INHIBITOR
- CHEK2 INHIBITOR
- kinase inhibitor
Cross-references
Synonyms
- Sra737
- CCT-245737
- CCT245737
- CCT245737 FREE BASE
- PNT-737
- PNT737
- SRA737
- QB6LNL4NF6
- RefChem:932145
- Chk1 Inhibitor SRA737
- Chk1 Inhibitor CCT245737
- Checkpoint Kinase 1 Inhibitor CCT245737
- SRA-737 [WHO-SDG]
- MFCD30489721
- UNII-QB6LNL4NF6
- GTPL9187
- orb1300093
- SCHEMBL15392098
- SCHEMBL29374363
- SRA 737 [WHO-DD]
- US9663503, Compound 1
- C16H16F3N7O
- YBYYWUUUGCNAHQ-LLVKDONJSA-N
- BDBM328993
- GLXC-10700
- SRA737; PNT-737
- EX-A1607
- PJC38918
- NSC793726
- AKOS030629815
- CCG-268393
- compound 4 [PMID: 27167172]
- CS-5863
- NSC-793726
- SRA737(CCT245737)?
- AC-36122
- BS-15458
- HY-18958
- T7080
Look up SRA-737 in the interactive SynDRA portal →